28 Stocks Moving In Monday's Pre-Market Session

Gainers

• Genomic Health, Inc. GHDX shares rose 33.6 percent to $53 in pre-market trading after the company disclosed that the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, successfully defined the benefit of chemotherapy in early-stage breast cancer patients with Oncotype DX Breast Recurrence Score® results of 11 to 25.
• SecureWorks Corp. SCWX rose 22.6 percent to $12.85 in pre-market trading. SecureWorks is expected to release Q1 results on June 6.
• Digital Ally, Inc. DGLY rose 15.1 percent to $3.05 in pre-market trading after the company reported that the US Patent Office has denied Axon's request to invalidate a Digital Ally patent.
• vTv Therapeutics Inc. VTVT rose 11.2 percent to $2.09 in pre-market trading after gaining 5.62 percent on Friday.
• Tenax Therapeutics, Inc. TENX rose 9.8 percent to $6.70 in pre-market trading.
• Nordic American Tankers Limited NAT rose 9.4 percent to $2.57 in pre-market trading.
• AGM Group Holdings Inc. AGMH rose 8.6 percent to $11.00 in pre-market trading. AGM Group reported that it has acquired a Hong Kong-based asset manager and announced plan to launch asset management business in Hong Kong.
• Loxo Oncology, Inc. LOXO rose 7.7 percent to $201 in pre-market trading after disclosing positive interim clinical data from LOXO-292 dose escalation trial in RET-altered cancers.
• SELLAS Life Sciences Group, Inc. SLS shares rose 5.8 percent to $5.85 in pre-market trading after gaining 6.55 percent on Friday.
• TransEnterix, Inc. TRXC rose 5.3 percent to $3.95 in pre-market trading after climbing 5.63 percent on Friday.
• Sears Holdings Corporation SHLD shares rose 4 percent to $2.37 in pre-market trading after dropping 18.86 percent on Friday.
• Petróleo Brasileiro S.A. - Petrobras PBR shares rose 3.8 percent to $10.51 in pre-market trading after falling 14.59 percent on Friday.
• JinkoSolar Holding Co., Ltd. JKS rose 3.7 percent to $15.70 in pre-market trading after dropping 14.07 percent on Friday.
• Anheuser-Busch InBev SA/NV BUD rose 3.4 percent to $96.61 in pre-market trading.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Nektar Therapeutics NKTR shares fell 24.7 percent to $68.00 in pre-market trading. Nektar and Bristol-Myers Squibb reported preliminary data for NKTR-214 in combination with opdivo for patients with Stage IV metastatic melanoma, renal cell carcinoma, and urothelial cancers.
• Jounce Therapeutics, Inc. JNCE fell 18 percent to $9.20 in pre-market trading after the company presented preliminary data from its ongoing Phase 1/2 ICONIC trial of JTX-2011 in patients with advanced solid tumors.
• Cara Therapeutics, Inc. CARA fell 14.8 percent to $13.04 in pre-market trading after dropping 2.11 percent on Friday.
• Myriad Genetics, Inc. MYGN fell 9.8 percent to $35.61 in pre-market trading after rising 8.11 percent on Friday.
• Co-Diagnostics, Inc. CODX fell 9 percent to $4.36 in pre-market trading after climbing 65.17 percent on Friday.
• Viking Therapeutics, Inc. VKTX fell 7.3 percent to $9.04 in pre-market trading after dropping 2.40 percent on Friday. Viking Therapeutics shares more than doubled Thursday after a 145-percent jump in shares of Madrigal Pharmaceuticals, which announced data from a Phase 2 study of its non-alcoholic steatohepatitis pipeline candidate.
• Cytori Therapeutics, Inc. CYTX shares fell 6.5 percent to $2.61 in pre-market trading after rising 7.31 percent on Friday.
• CRISPR Therapeutics AG CRSP fell 5.4 percent to $63.50 in the pre-market trading session after declining 2.58 percent on Friday.
• bluebird bio, Inc. BLUE fell 5.2 percent to $173.00 in pre-market trading. Celgene and bluebird bio reported updated results from CRB-401 phase I clinical study of bb2121 in patients with late-stage relapsed/refractory multiple myeloma.
• Blueprint Medicines Corporation BPMC shares fell 4.8 percent to $80.45 in pre-market trading. Blueprint Medicines and CStone Pharmaceuticals reported a partnership and license agreement to develop and commercialize Avapritinib, BLU-554 and BLU-667 in Greater China.
• Daqo New Energy Corp. DQ shares fell 4.8 percent to $50.21 in pre-market trading after dropping 8.57 percent on Friday.
• Xunlei Limited XNET fell 4.4 percent to $11.90 in pre-market trading.
• Jernigan Capital, Inc. JCAP shares fell 3.8 percent to $19.02 in pre-market trading.
• HDFC Bank Limited HDB fell 3.5 percent to $102 in pre-market trading.